£
Donate

We're here for you if you want to talk

0808 2080 888

[email protected]

Chronic myeloid leukaemia (CML) prognosis

We're here for you if you want to talk

0808 2080 888

[email protected]

After you’ve been diagnosed with CML, you may want to know more about your prognosis – what's likely to happen in the future.

Thanks to tyrosine kinase inhibitors (TKIs), survival rates for people with chronic myeloid leukaemia (CML) have improved dramatically over the last 20 years.

Most people with CML will have a very good prognosis – particularly those diagnosed in the chronic phase. Recent evidence suggests that if you respond well to treatment, you could have a similar life expectancy to someone who doesn’t have cancer.

Unfortunately, it’s harder to control blast phase CML, as it doesn’t always respond to TKIs. If this is the case for you, your healthcare team will talk you through other treatment options and explain the impact they might have on your prognosis.

Ask your healthcare team about your prognosis

We have general information about things that might affect your prognosis, but everyone is different. If you want to know about your individual prognosis, your healthcare team are the best people to ask. They know you and your individual situation.

Our research impact on CML

Our pioneering research into chronic myeloid leukaemia (CML) has played a dramatic role in improving treatment and survival rates for CML.

A woman takes a call on a headset as she works from home, looking at the computer in front of her. She's seated at a leather office chair with a filing cabinet and window behind her.

Worried or have questions about prognosis?

We can talk you through it

Support for you

We're here for you if you want to talk

0808 2080 888

[email protected]